|
|
|
|
Program Session Overview
| InterAction Meetings, Bryn Mawr College, Philadelphia
Last Held October 2006 and 2007; Next Meeting 14-17 October 2008 | | Focus: Critical Path Advances in Drug Development, Innovation & Knowledge Management in R&D and Clinical Research, Decision Support & Analytics, Drug Safety, Metabolomics, Biomarkers, Medicinal Chemistry, Drug Discovery Innovation, Screening, Structural Biology, Toxicology, Systems Biology | | Format: Roundtables, Presentations, Panel Q&As, Discussions, Break-out workshops, Networking, Web-supported | More information on 2006-2008 programs.
|
|
|
InterAction Meeting Proceedings 2005
| Basel, Switzerland, 9-10 November 2005 (Proceedings available through website)
Knowledge Management in R&D: optimising productivity in knowledge creation,capture, retrieval and transfer, chaired by Robert Scoffin (CambridgeSoft)
Alan Gibbs (Johnson & Johnson Pharmaceutical Research & Development, LLC), Kim Henrick, (European Bioinformatics Insititute), Ulrich Jordis (Vienna University of Technology), Steve Gardner (Biowisdom), Michael Swartz (CambridgeSoft), Pierre Allemand (Symyx AG), Victor Newman (The Knowledgeworks), Mark Sharp (Corpora), Rolf Jautelat (Schering AG), Jeff Spitzner (Rescentris), Barry Hardy (Douglas Connect)
More Information...
Life Science Innovation Café - Confidence in Safety
A special workshop moderated by Victor Newman (Knowledgeworks) supported by expert panel
More Information...
Confidence in Drug Safety, chaired by Saad Shakir (Drug Safety Research Unit, UK)
Sidney Kahn (Pharmacovigilance & Risk Management, Inc.), A. Leander Fontaine (pharmiceutics, LLC), Peter Elkin (Mayo Clinic)
More Information...
Drug Discovery Innovation, chaired by Alan Gibbs (Johnson & Johnson Pharmaceutical Research & Development, L.L.C.)
Alan Gibbs (Johnson & Johnson Pharmaceutical Research & Development, LLC), Lars M. Blank (University of Dortmund and the Institute for Analytical Sciences (ISAS), Dortmund), Steve Boyer (IBM), Gérard Hopfgartner (University of Geneva), Jeroen H. Nieuwenhuis (Philips Research)
More Information...
Knowledge-based Intellectual Property Management, Auditing and Investment, chaired by Ronald Layden (Venture Valuation AG)
Rudolf Gygax (Novartis Venture Fund), Nigel Sheail (Roche), Ronald Layden (Venture Valuation), Gerard Farmer (Alfomec International Regulatory Consultants), Stefan Odenthal (Arthur D. Little)
More Information...
Biosensors and Nanofluidics, chaired by Nick Quirke (Imperial College London)
Andrew De Mello (Imperial College London), Jens Walther (ETH-Zurich), Nick Quirke (Imperial College London), Joachim Franzke (ISAS, Dortmund)
More Information...
Philadelphia, US, 11-12 October 2005 (Proceedings available through website)
Drug Safety Knowledge Management; Confidence in Safety, chaired by Sidney Kahn (PvRM)
Sidney Kahn (PvRM, Inc.), A. Leander Fontaine (pharmiceutics, LLC), James Averback (Life Science Integration Partners), Peter Elkin (Mayo Clinic)
More Information...
Drug Discovery Innovation, chaired by David Mosenkis
Victor Lobanov (Johnson & Johnson Pharmaceutical Research & Development, L.L.C.), Jeff Wiseman (Locus Pharmaceuticals), James H Wikel (Coalesix), G. Scott Lett (Bioanalytics Group), Randy J. Zauhar (University of the Sciences in Philadelphia)
More Information...
Web-based Services in Drug Design, chaired by Marc Nicklaus (National Institutes of Health)
Brett Tounge (Johnson & Johnson Pharmaceutical Research & Development, LLC), Brad Feuston (Merck), John Irwin (UCSF), Steve Bryant (NCBI), David Covell (National Cancer Institute), Dmitrii Rassokhin (Johnson & Johnson Pharmaceutical Research & Development, LLC)
More Information...
Personalized Medicine: Safety and Efficacy Concerns Discussed as a Case-Study, chaired by Donna Mendrick (Gene Logic)
Sydney Gilman (Gene Logic), Matt Cooper (Biogen Idec), Derek Janszen (Wyeth), Steven Arnold (Queens-Long Island Medical Group), Donna Mendrick (Gene Logic)
More Information...
Knowledge Management in R&D: optimising productivity in knowledge creation,capture, retrieval and transfer, chaired by Herschel J Weintraub (CambridgeSoft)
Peter Gates (Johnson & Johnson Pharmaceutical Research & Development, LLC), John Barrett (ITI Associates), Scott Starry (Symyx IntelliChem), Jeff Spitzner (Rescentris), James H Wikel (Coalesix), Bonnie Montano (Georgetown University), Rosemary Polsky-Newman (ExerGen Biosciences), Michael Liebman (Windber Research Institute), James M. Kanagy (GlaxoSmithKline)
More Information...
Protein Folding, Misfolding & Aggregation: Applications to Disease, chaired by Nikolay V. Dokholyan (University of North Carolina)
David Teplow (David Geffen School of Medicine at UCLA), Feng Ding (University of North Carolina), Andrew Miranker (Yale University), Richard Dixon (University of North Carolina)
More Information...
|
|
|
|
|
|
|
|
|
|
